你是 stock-analyst v20 DD 的證據採集子 agent。標的：DXCM。
你負責下列 1 個覆蓋軸，逐軸獨立查證，**本軸最多 4 次 WebSearch**（每一類題目一次），查不到就記 none，不要一直挖。

[substitute_technology] 替代技術
Q: 是否存在正在崛起、可能取代本標的核心產品/技術的替代方案？
  - DexCom product substitute technology threat 2026
  - Medical Devices alternative technology disruption 2026 2027
  - DXCM DexCom technology obsolescence risk
  - Medical Devices next-generation technology roadmap 2026


## 規則（嚴格遵守，違反視為無效輸出）
1. **只回 sourced claim**：每條 finding 必須有可查證的 source（URL 或明確可搜尋到的來源名＋標題）與 as_of（該資訊的發布/生效日期，非你查詢的日期）。
2. **查不到就 status="none"**，並列出你實際下過的 queries_run（至少 1 條，需與你實際搜尋詞一致，不得事後編造）。軸清單裡的 `queries` 是起點不是配額，同一次搜尋的來源可同時支撐多個軸。**不得因為查無所獲就用訓練知識/常識填 claim。**
3. **三種狀態不得混用**：found＝有 sourced claim；none＝軸適用於本標的業態、但搜尋查無來源；not_applicable＝該軸對本標的業態根本不成立（例：銀行沒有「最大客戶導入第二供應商」、零售商的客戶是終端消費者）。**軸對此業態不適用時回 not_applicable 並在 note 寫理由，不要回 none。**只有軸物件標 na_allowed=true 才可回 not_applicable，沒標的軸只能 found 或 none；拿不準是否適用就當適用、照常搜尋，不要用 not_applicable 省搜尋。
4. **不臆測、不外推**：claim 只寫你實際找到的事實，不要自己推論「這意味著」，那是判斷層的工作。
5. direction 欄：這條 finding 對本標的是正面(+)／中性(0)／負面(-)，僅標事實方向，不要寫成裁決語。
6. affects 欄：這條 finding 影響哪些判斷面（可填 moat_trend／thesis.H／thesis.R／decision_inputs.bear／valuation／triggers 等，可複選）。
7. **現價一律引 `numbers.price_at_dd`／`price_as_of`，不得自行寫「現價」數字**：市值、距 52 週高低點 %、目標價 vs 現價，一律引用該欄，不從聚合站另抓現價字面數字。
8. **原始證據與解讀分開存**：每條 finding 另填三欄——`url`（實際讀到的網址，沒有就填 null）、`excerpt`（從該來源**逐字複製**、支撐 claim 的原文，≤300 字，不得改寫或翻譯）、`excerpt_from`（`snippet`＝搜尋摘要／`page`＝WebFetch 讀到的頁面）。`claim` 是你對原文的精簡轉述；`excerpt` 是證據本身。找不到可逐字複製的原文就填 null，不要自己寫一句當原文。

## 程式已抓好的一手文件摘錄（本軸）
以下為程式抓取的一手文件摘錄，可直接逐字引用（附 url 與 as_of）：
- 引用時 finding 的 `url`、`as_of` 照該則標示填；`source` 寫「來源＋文件」；`excerpt` 從「<<<」「>>>」之間**逐字複製**（≤300 字，取最能支撐 claim 的連續一段，不改寫、不翻譯）；`excerpt_from` 填 `"page"`。
- 一手清單顯示沒有某類事件時（例如「標題含關鍵字者 0 則」），可據此寫一條「經查一手紀錄無此類事件」的 finding（status=found、direction=`"0"`），excerpt 用清單本身那一句統計；不要因為沒找到事件就標 none。
- 這些摘錄不算你的搜尋：`queries_run` 只記你自己實際下過的搜尋；摘錄仍可另外搜尋補充，但不必為了湊證據重搜摘錄已涵蓋的內容。
- 摘錄與本軸問題無關或不足以回答時，照常搜尋；仍查不到才記 none。

[1] 來源：SEC EDGAR｜文件：10-K（FY2025，申報 2026-02-12）｜章節：Item 1. Business｜url：https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/dxcm-20251231.htm｜as_of：2026-02-12
<<<
•Intuitive User Interface. We have developed a user interface that we believe is intuitive and easy to use. Our current CGM system receivers are compact with an easy-to-read color display, simple navigation tools, audible alerts and graphical display of trend information. Similar benefits are available via the interfaces we have made available on compatible mobile devices. These devices can serve as substitutes for our receivers or alternate display units in certain geographies.

Our patents and patent applications seek to protect aspects of our core membrane and sensor technologies and our product concepts for continuous glucose monitoring. We believe that our patent position provides us with sufficient rights to protect our current and proposed commercial products. However, our patent applications may not result in issued patents, and any patents that have been issued or might be issued may not protect our intellectual property rights. Furthermore, we operate in an industry characterized by extensive patent litigation, and our patents may not be upheld if challenged. Any patents issued to us may be challenged by third parties as being invalid or unenforceable, and patent litigation may result in significant damage awards and injunctions that could prevent the manufacture and sale of affected products or result in significant royalty payments in order to continue selling the products. Third parties may also independently develop similar or competing technology that avoids our patents. The steps we have taken may not prevent the misappropriation of our intellectual property, particularly in international countries where the laws may not protect our proprietary rights as fully as in the United States. We also face risks associated with intellectual property infringement.
>>>

[2] 來源：SEC EDGAR｜文件：10-K（FY2025，申報 2026-02-12）｜章節：Item 1A. Risk Factors｜url：https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/dxcm-20251231.htm｜as_of：2026-02-12
<<<
In 2023, we completed the initial phase of construction of our new facility in Malaysia and commenced commercial manufacturing. We are also building a new facility in Ireland to scale up manufacturing capacity. There are technical challenges to increasing manufacturing capacity, including equipment design, automation, validation and installation, contractor issues and delays, licensing and permitting delays or rejections, materials procurement, manufacturing site expansion, problems with production yields and quality control and assurance. Continuing to develop commercial-scale manufacturing facilities will require the investment of substantial additional funds and the hiring and retention of additional management, quality assurance, quality control and technical personnel who have the necessary manufacturing experience. Delays in the launch of next-generation products may result in unanticipated continuing increases in demand for current-generation products (to substitute for the unavailability of the next-generation products) which, if not adequately prepared for, may result in deficits in our ability to produce adequate amounts of the prior-generation products to meet demand at appropriate prices.

We are subject to risks associated with public health issues, such as the previous COVID-19 pandemic, and other events beyond our control. Public health issues and crises may adversely impact our operations, supply chain and logistics network if the locations where we operate, manufacture or distribute our products; where our raw materials or products are sourced, manufactured or distributed; or where our third-party distributors, suppliers and other service providers operate, are disrupted, temporarily closed or experience worker shortages for a sustained period of time. In addition, public health issues and crises may adversely impact our customers and/or their businesses due to lockdowns, labor shortages, lost access to private health insurance plans or modified spending priorities, all of which could cause a decline in demand for our products. These disruptions could also cause economic slowdowns or increased economic uncertainty. Any of the forgoing could adversely affect our business, financial condition and results of operations.

In the ordinary course of our business, we collect and store sensitive data, such as our proprietary business information and that of our clients, contractors, vendors and others as well as personally identifiable information of our customers, potential customers, vendors and others, which data may include sensitive information, in our data centers and on our networks. Our employees, contractor and vendors may also have access to and may use personal health information in the ordinary course of our business. The secure processing, maintenance and transmission of this information is critical to our operations. Despite our security measures and business controls, our information technology and infrastructure may be vulnerable to attacks by hackers (including nation states or 41 state-sponsored organizations), viruses, malware, breaches due to employee, contractor or vendor error, or malfeasance or other disruptions or subject to the inadvertent or intentional unauthorized release of information. Any such occurrence could compromise our networks and the information stored thereon could be accessed, publicly disclosed, lost or stolen.…

These threats can come from a variety of sources, including criminal hackers, state-sponsored intrusions, industrial espionage and malfeasance by employees, contractors, or other insiders. Cyber threats may be generic, or they may be custom-crafted against our information systems or particular personnel. Over the past several years, cyberattacks have become more prevalent and much harder to detect and defend against. These threat actors may be able to penetrate our security measures, breach our information technology systems, misappropriate or compromise confidential and proprietary information of our company and our customers, cause system disruptions and shutdowns, or introduce ransomware, malware, or vulnerabilities into our products, systems, and networks or those of our customers and partners. Our network and storage applications, as well as those of our contractors, may be vulnerable to cyber-attack, malicious intrusion, malfeasance, loss of data privacy or other significant disruption and may be subject to unauthorized access by hackers, employees, consultants or other service providers. In addition, products, hardware, software or applications we develop, or which we procure from third parties, may contain defects in design or manufacture, security flaws, or other problems that could unexpectedly compromise information security or the operation of our products. Our third-party vendors may experience security incidents of varying severity, including but not limited to increased ransomware attacks, network intrusions, and unauthorized data exfiltration.…

Moreover, we are subject to various operational, compliance, and reputational risks associated with our adoption and utilization of AI technologies, including inaccurate or unpredictable outputs, such as errors or hallucinations, that may impair decision‑making, disrupt operations, or expose sensitive information. Integrating AI into our systems may also expand our cybersecurity attack surface, increasing exposure to data breaches, loss of intellectual property, or inadvertent disclosure of confidential data. Although we have taken steps intended to mitigate risks related to our use of AI, there can be no assurance that our use of AI will yield the anticipated benefits or that we will be able to effectively mitigate the associated risks. Externally, the rapid adoption of AI by competitors and malicious actors heightens risks as threat actors leverage AI to execute more sophisticated cyberattacks and social‑engineering campaigns, while competitor use of AI may accelerate innovation cycles and intensify competitive pressures. Any of these events could have a material adverse effect on our business, financial condition and results of operations.

We rely on information technology and telephone networks and systems, including the Internet, to process and transmit sensitive electronic information and to manage or support a variety of business processes and activities, including sales, billing, customer service, procurement and supply chain, manufacturing, and distribution. We use enterprise information technology systems to record, process, and summarize financial information and results of operations for internal reporting purposes and to comply with regulatory financial reporting, legal, and tax requirements. System failures or outages, including any potential disruptions due to significantly increased global demand on certain cloud-based systems, or failures to adequately scale our data platforms and architectures support patient care could compromise our ability to perform these functions in a timely manner, which could harm our ability to conduct business or delay our financial reporting. Such failures could materially adversely affect our operating results and financial condition.…

Climate change may have an adverse impact on our business. While we seek to partner with organizations that mitigate their business risks associated with climate change, we recognize that there are inherent risks related to climate change wherever business is conducted. Ensuring business resiliency through mitigating climate-related risks in the communities where we conduct our business is a priority, whether for our offices or for our stakeholders. Our manufacturing sites in Ireland, Arizona and Malaysia and our global operations, including California and the Philippines, are vulnerable to climate change effects. For example, in California and Arizona, increasing intensity of droughts throughout the states and annual periods of wildfire danger increase the probability of planned and unplanned power outages in the communities where we work and live. While this danger has a low-assessed risk of disrupting normal business operations, it has the potential impact on employees’ abilities to commute to work or to work from home and stay connected effectively. Climate-related events, including the increasing frequency of extreme weather events and their impact on the U.S., the Philippines, Malaysia, Ireland and other major regions’ critical infrastructure, have the potential to disrupt our business, our third-party suppliers, and/or the business of our customers, and may cause us to experience higher attrition, losses, and additional costs to maintain or resume operations.
>>>


## 回傳格式（嚴格 JSON 契約，不得夾雜其他文字；一次 Write）
```json
{
  "coverage": {
    "<axis_id>": {
      "status": "found|none|not_applicable",
      "queries_run": ["...", "..."],
      "findings": [
        {"claim": "...", "source": "...", "url": "https://...", "excerpt": "逐字原文…", "excerpt_from": "snippet|page", "as_of": "YYYY-MM-DD", "direction": "+|0|-", "affects": ["moat_trend"]}
      ],
      "note": "",
      "clues": [
        {"claim": "...", "source": "...", "url": "https://...", "as_of": "YYYY-MM-DD", "direction": "+|0|-", "affects": ["moat_trend"], "match_terms": ["預期原文逐字出現的字串", "..."]}
      ]
    }
  }
}
```

`clues` 選填、每軸一個陣列，沒有就整個欄位省略。只在你**找到有網址的線索、但沒讀到頁面而拿不到可逐字複製的原文**時放；程式會打開該網址，在全文裡找 `match_terms` 同時出現的一段原文，找到就升級成帶原文的 finding；找不到（或頁面打不開）就照 `excerpt_from: "snippet"`、`excerpt: null` 的 finding 保留，並標為未核原文。
- 只有 clues、findings 是空的時，`status` 填 `none`（程式核實到原文後會自動改成 `found`）。
- `url` 必須是你在搜尋結果裡實際看到的網址；不得編造、不得猜網址、不得填網站首頁。沒有網址的線索不要放（寫進 note）。已經寫在 findings 的網址不要重複放。
- `match_terms` 放 2～5 個預期原文會逐字出現的字串：金額、比例、專有名詞、引號裡的關鍵詞。照原文可能的寫法填，不要改寫或翻譯；不要放公司名、代號、年份或「營收」「公司」這類到處都有的詞。
- 其餘欄位（`claim`、`source`、`as_of`、`direction`、`affects`）規則同 findings；`as_of` 填你推估的文章發布日，程式讀到頁面發布日會以頁面為準。

寫入路徑：`/Users/ivanchang/financial-analysis-bot/.dd_build/runs/DXCM_20261102/parts/axes_9.json`（用 Write 工具寫一次，不要分次 Edit）。

## 輪次紀律
你只有 WebSearch、WebFetch、Write 三個工具，沒有 Bash。**寫完 part 檔就停止**，不要自己驗證、不要重讀、不要回報長文。驗證由程式做；缺欄程式會把該軸記成缺口，不會叫你重寫。
搜尋：本軸最多 4 次；WebFetch 只在搜尋摘要不足以寫出 as_of 與 claim 時才用，每軸最多 2 次。

回報 ≤50 字：完成幾軸、found/none 各幾軸。
